Repligen Corporation (RGN)
FSX
Real-time Data
06:00 AM
Day's Range
154.3552 wk Range
86.32Overview - RGN - Repligen Corporation
Key Statistics
Valuation
Enterprise Value
7.26B
P/E (Trailing)
‪242.46‬
P/E (Forward)
‪50.57‬
PEG Ratio
‪-3.70‬
Price / Sales (TTM)
‪10.98‬
Price / Book
‪4.69‬
EV / EBITDA
‪58.99‬
Profitability
Gross Margin
‪53.90%‬
Profit Margin
‪5.29%‬
Operating Margin
‪9.30%‬
Return on Assets
‪1.39%‬
Return on Equity
‪1.99%‬
Ownership
Shares Outstanding
56.42M
Float
53.47M
Held by Insiders
‪5.24%‬
Held by Institutions
‪120.03%‬
Price stats
Beta
‪1.01‬
50-Day Avg
‪125.99‬
200-Day Avg
‪119.17‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - RGN - Repligen Corporation
Peers - RGN - Repligen Corporation
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on FSX.
Profile Summary - RGN - Repligen Corporation
About
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems to support the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Headquartered in Waltham, Massachusetts, it serves…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
